AURX OTC
Nuo Therapeutics, Inc.
1W: -2.3%
1M: +9.7%
3M: +23.8%
YTD: -37.5%
1Y: -35.9%
3Y: +4.2%
5Y: +177.8%
$1.25
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$3M
+142.7% ▲
Gross Profit
$2M
+108.8% ▲
Operating Income
-$3M
-2.4% ▼
Net Income
-$3M
-8.1% ▼
EPS (Diluted)
$-0.05
+2.3% ▲
EBITDA
-$3M
-6.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $112K | $609K | $1M | $3M |
| YoY Growth | +0.0% | +0.0% | +442.1% | +124.3% | +142.7% |
| Cost of Revenue | $0 | $19K | $126K | $303K | $1M |
| Gross Profit | $0 | $93K | $482K | $1M | $2M |
| Gross Margin | — | 82.9% | 79.3% | 77.8% | 66.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $91K | $3M | $4M | $4M | $5M |
| Operating Expenses | $91K | $3M | $4M | $4M | $5M |
| Operating Income | -$91K | -$3M | -$3M | -$2M | -$3M |
| Operating Margin | — | -2958.2% | -520.6% | -180.0% | -76.0% |
| Interest Expense | $0 | $2K | $3K | $0 | -$804 |
| Income Before Tax | -$91K | -$3M | -$3M | -$2M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$91K | -$3M | -$3M | -$2M | -$3M |
| Net Margin | — | -2695.1% | -521.2% | -170.2% | -75.8% |
| EPS (Diluted) | $-0.00 | $-0.08 | $-0.08 | $-0.05 | $-0.05 |
| EBITDA | $0 | -$3M | -$3M | -$2M | -$3M |
| Shares Outstanding | 30M | 40M | 42M | 45M | 47M |